Cryptococcosis is a fungal infection caused by genus Cryptococcus, that includes 10 species, being five species of the Cryptococcus gattii identified through phylogenetic analysis (LIU et al., 2012; HAGEN et al., 2015). Cryptococcus neoformans and Cryptococcus gattii are often associated with pulmonary and systemic infections in humans and animals (CHEN et al., 2014).
During the past two decades, several C. gattii sensu lato outbreaks have been reported, characterized as an emerging disease with great interest in public health. The main route of transmission of Cryptococcus is from inhalation of infectious propagules by immunocompromised as well as immunocompetent animals (CHEN et al., 2014). Cryptococcosis in horses is associated mainly with lesions in the respiratory tract, central nervous system (CNS), and abortion. However, disseminated cryptococcosis is reported with involvement of several systems concomitantly (ZOPPA et al., 2008). This reported describes a case of equine nasopharyngeal cryptococcoma due to C. gattii.
A 10-year-old crossbred mare, belonging to a jockey club in Porto Alegre, state of the Rio Grande do Sul, Brazil, initially manifested apathy, weight loss, dyspnoea, and dysphagia as well as abundant discharge from the left nostril composed of serum and exudate. On endoscopic examination, a mass obstructing the entry of the oropharynx was demonstrated. Due to poor prognosis the owner decided euthanasia. Only the head of the horse was sent for examination. A sagital cross section through the cranium revealed an asymmetric mass adhered to the ethmoid sinuses in the nasal cavity, with a portion extending over 8.0cm to the nasal turbinate and another portion forming a rounded mass of 4.0cm in diameter obstructing the oropharynx. The mass had a slightly uneven surface, white solid cut surface with soft consistency, and moderately delimited by a yellow capsule (Figure 1A). Fragments of the mass were fixed in 10% neutral buffered formalin and processed routinely. Sections were stained by haematoxylin and eosin (HE), in addition to histochemical techniques of periodic acid-Schiff (PAS), Alcian blue (AB), as well Mayer’s mucicarmine (MM).

Figure 1 (A) Sagital cross section through the cranium revealed an asymmetric mass adhered to the ethmoid sinuses in the nasal cavity. (B) Multiple spherical to oval yeasts cells of Cryptococcus gattii shows unstained halo (mucopolysaccharidic capsule). (C) Cryptococcal organisms and the surrounding polysaccharide capsules stained pink with Mayer’s mucicarmine stain. MM. (D) Cryptococcal organisms and the surrounding polysaccharide capsules stained blue with Alcian Blue stain. AB.
Microscopic examination of the mass revealed multiple spherical to oval yeasts cells, 4-8µm in diameter, with some of them exhibiting narrow-based polar budding. A negatively stained capsule gives these cells the aspect of having a clear zone of variable thickness around them imparts a typical soap-bubble appearance to the histological sections. A slightly infiltrate that consisted predominantly of macrophages with abundant extracellular organisms, associated with moderate fibrosis, was also observed. There was no evidence of fungal infection of the brain. The capsule of the yeast was demonstrated on PAS (Figure 1B) staining which was further highlighted by MM stain (Figure 1C), imparting it a red color confirming that capsular polysaccharide was present. The polysaccharide capsule stained blue with AB stain (Figure 1D).
Tissue fragments were plated on Sabouraud Dextrose Agar with chloramphenicol and incubated at 30°C for 48h. In addition, the isolate was discriminated by a color reaction when grow on canavanine-glycine-bromothymol blue (CGB) agar. Reaction on CGB agar was considered positive after 48h of incubation. Morphologically, spherical to oval encapsulated yeast cells, budding on a narrow base range from 4-10µm in diameter. The CGB agar turned blue, characterizing the colonies as C. gattii.
The PureLinkTM Genomic DNA Mini Kit (Invitrogen) was used for DNA extraction from the tissue fragment. DNA extracted was detected with panfungal PCR using ITS3-F (5’-GCATCGATGAAGAACGCAGC-3’) and ITS4-R (5’-TCCTCCGCTTATTGATATGC-3’), which amplify the ITS1 and/or ITS2 regions of fungal rDNA genes (WHITE et al., 1990). PCR amplification was performed in a 25μL containing 1μL of DNA extract, 12.5μL Qiagen Taq PCR master mix (Qiagen, Hilden, Germany) and 0.5μL of each primer (for a 0.2μM final concentration of each primer). After a preincubation at 94°C for 15min, the amplification was performed for a total of 35 cycles as follows: denaturation at 94°C for 30s, annealing at 57°C for 90s, extension at 72°C for 1min, and a final extension step of 10min at 72°C. Primers ITS3 and ITS4 amplified a fragment of between 300 and 400bp. The amplification positive control included genomic DNA from C. gattii. PCR product was separated on a 2% agarose. PCR product was purified using PureLinkTM PCR Purification Kit (Invitrogen), and sequencing to confirm the presence of fungal elements in the tissue sample.
The horse presented here showed clinical signs similar to those described in nasal cavity infections by C. gattii in cats and humans, which are characterized by apathy, anorexia, lethargy, and bilateral nasal discharge of serous to hemorrhagic aspect (MALIK et al., 1997; CHEN et al. 2014, KINNE et al., 2017). The difficulty in swallow and breath, observed here, is also reported in nasopharyngeal granulomas by Cryptococcus in other animal species (MALIK et al., 1997). There are several reports of cryptococcosis in horses affecting the CNS (CHO et al., 1986) and respiratory tract (ZOPPA et al., 2008). Equine nasal granulomas are rarely described, but two systemic equine cryptococcosis reports by Cryptococcus in Australia and Brazil have clinical and morphological finding, respectively, with characteristics similar to those reported in the case presented here. It is suggested that the mechanism of transmission was through the inhalation of fungus propagules (KOMMERS et al., 2005; ZOPPA et al., 2008).
Cryptococcus is yeast with thick mucopolysaccharide capsule that does not stain by Indian Ink and is seen as a clear halo, ranging from 1 to 30µm of thickness (CASWELL& WILLIAMS, 2016). Different other fungi like Coccidioides sp. which have oval structures measuring 20-200µm in diameter containing multiple intracellular endospores observed in HE stain. Besides of the Rhinosporidium sp., are observed spherical to polygonal structures of variable appearance measuring approximately 100-500µm filled with endospores measuring 3-5µm (BERROCAL et al., 2007, CASWELL & WILLIAMS, 2016). The PAS and AA stains were applied to confirm the mucopolysaccharide capsule, consequently the yeast was uniformly positive by MM stain, except in cryptococcosis by nonencapsulated yeast-like organisms, in which the usual color appearance is absent. Inflammatory reaction seen is the histopathology examination of the case presented here, which demonstrated a well delimited mass with moderate fibrous stroma interspersed with a large quantity of yeast cells and slightly histiocytic infiltrate, being characterized as a cryptococcoma (SCHWARTZ, 1988). In vitro studies and experimental inoculations suggested that C. gattii is capable of inhibiting neutrophils migration, and that the metabolites produced by it has less pro-inflammatory capacity compared to C. neoformans (WRIGHT et al., 2002).
There are several reports of mass formation in the nasal cavity of horses related to fungal infections as Conidiobolus and Coccidioides immitis (CASWELL & WILLIAMS, 2016), Aspergillus (GUIDA et al., 2005), Rhinosporidium seeberi (previously classified as a fungus) (LEEMING et al., 2007), in addition to formation of nasal polyps, ethmoid hematomas, and tumors (CASWELL & WILLIAMS, 2016). Clinical and microscopic findings are similar, so the histopathology and culture from a clinical sample are the standard reference tests for diagnosis of fungal infection. (GUARNER et al., 2011; BERROCAL et al., 2007).
Molecular methods for the differentiation of C. neoformans and C. gattii are needed when the conventional methodology (histopathology and culture) does not allow the correct identification. Similar methodology was performed in the outbreak by C. gattii in humans and animals occurred in Vancouver, Canada (GALANIS et al., 2009). In our study, although the C. gattii was CGB positive, PCR with primer panfungal was necessary to confirm its identity, since is a valuable tool when used in conjunction with histopathology (the assay has the ability to identify fungi in tissue specimens) and culture in order to confirm fungal infections in animals. Thus, in some cases, such as differentiation of Cryptococcus species, it might be superior to culture alone; although, culture remains the standard reference test.
The determination of the species was important because infections by C. gattii are increasingly considered worrisome since this species is not susceptible to the most commonly used antifungal agents, which makes the treatment more difficult (TRILLES, 2004). In present case, the horse was euthanized after diagnosis of nasopharyngeal mass and there was no history of antifungal treatment.
Due to the fact that only the head of the mare was sent for analysis it was impossible to rule out the possibility of evaluation of disseminated cryptococcosis. To date there are no data regarding the occurrence of C. gattii infection in horses in this area as reported in this case. The diagnosis of severe injury by C. gattii in the case here presented and the various reports of infection in humans and animals characterized the C. gattii as an emerging fungal pathogen (LESTER et al., 2011, CHEN et al., 2014). So there is an awareness of the disease to the need for more accurate diagnostic investigation when suspected clinical manifestations. C. gattii should be included as one of the possible primary agents of granulomatous rhinitis in horses.
The diagnosis of equine nasopharyngeal cryptococcoma due to Cryptococcus gattii was confirmed based upon the gross and microscopical findings, combined with mycological and molecular assays.